Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Regulation of the Staphylococcal Superantigen-Like Protein 1 Gene of Community-Associated Methicillin-Resistant Staphylococcus aureus in Murine Abscesses.

Bretl DJ, Elfessi A, Watkins H, Schwan WR.

Toxins (Basel). 2019 Jul 4;11(7). pii: E391. doi: 10.3390/toxins11070391.

2.

Virulence factor landscape of a Staphylococcus aureus sequence type 45 strain, MCRF184.

Aswani V, Najar F, Pantrangi M, Mau B, Schwan WR, Shukla SK.

BMC Genomics. 2019 Feb 8;20(1):123. doi: 10.1186/s12864-018-5394-2.

3.

Differential Regulation of Escherichia coli fim Genes following Binding to Mannose Receptors.

Schwan WR, Beck MT, Hung CS, Hultgren SJ.

J Pathog. 2018 May 22;2018:2897581. doi: 10.1155/2018/2897581. eCollection 2018.

4.

Temporal Regulation of fim Genes in Uropathogenic Escherichia coli during Infection of the Murine Urinary Tract.

Schwan WR, Ding H.

J Pathog. 2017;2017:8694356. doi: 10.1155/2017/8694356. Epub 2017 Dec 27.

5.

Identification of Staphylococcus aureus Cellular Pathways Affected by the Stilbenoid Lead Drug SK-03-92 Using a Microarray.

Schwan WR, Polanowski R, Dunman PM, Medina-Bielski S, Lane M, Rott M, Lipker L, Wescott A, Monte A, Cook JM, Baumann DD, Tiruveedhula VVNPB, Witzigmann CM, Mikel C, Rahman MT.

Antibiotics (Basel). 2017 Sep 11;6(3). pii: E17. doi: 10.3390/antibiotics6030017.

6.

Docking into Mycobacterium tuberculosis Thioredoxin Reductase Protein Yields Pyrazolone Lead Molecules for Methicillin-Resistant Staphylococcus aureus.

Sweeney NL, Lipker L, Hanson AM, Bohl CJ, Engel KE, Kalous KS, Stemper ME, Sem DS, Schwan WR.

Antibiotics (Basel). 2017 Jan 28;6(1). pii: E4. doi: 10.3390/antibiotics6010004.

7.

Osmolyte transport in Staphylococcus aureus and the role in pathogenesis.

Schwan WR, Wetzel KJ.

World J Clin Infect Dis. 2016;6(2):22-27. Epub 2016 May 25.

8.

Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92.

Schwan WR, Kolesar JM, Kabir MS, Elder EJ Jr, Williams JB, Minerath R, Cook JM, Witzigmann CM, Monte A, Flaherty T.

Antibiotics (Basel). 2015 Dec;4(4):617-626. Epub 2015 Nov 24.

9.

Design and synthesis of novel antimicrobials with activity against Gram-positive bacteria and mycobacterial species, including M. tuberculosis.

Tiruveedhula VV, Witzigmann CM, Verma R, Kabir MS, Rott M, Schwan WR, Medina-Bielski S, Lane M, Close W, Polanowski RL, Sherman D, Monte A, Deschamps JR, Cook JM.

Bioorg Med Chem. 2013 Dec 15;21(24):7830-40. doi: 10.1016/j.bmc.2013.10.011. Epub 2013 Oct 21.

10.

OmpR regulation of the uropathogenic Escherichia coli fimB gene in an acidic/high osmolality environment.

Rentschler AE, Lovrich SD, Fitton R, Enos-Berlage J, Schwan WR.

Microbiology. 2013 Feb;159(Pt 2):316-27. doi: 10.1099/mic.0.059386-0. Epub 2012 Nov 22.

11.

Antibacterial spirobisnaphthalenes from the North American cup fungus Urnula craterium.

Liu XT, Schwan WR, Volk TJ, Rott M, Liu M, Huang P, Liu Z, Wang Y, Zitomer NC, Sleger C, Hartsel S, Monte A, Zhang L.

J Nat Prod. 2012 Sep 28;75(9):1534-8. Epub 2012 Aug 30.

PMID:
22934636
12.

Escherichia coli pyomyositis in an immunocompromised host.

Sharma U, Schwan WR, Agger WA.

WMJ. 2011 Aug;110(4):182-4. Review.

13.

Regulation of fim genes in uropathogenic Escherichia coli.

Schwan WR.

World J Clin Infect Dis. 2011 Dec 30;1(1):17-25.

14.

Synthesis and minimum inhibitory concentrations of SK-03-92 against Staphylococcus aureus and other gram-positive bacteria.

Schwan WR, Kabir MS, Kallaus M, Krueger S, Monte A, Cook JM.

J Infect Chemother. 2012 Feb;18(1):124-6. doi: 10.1007/s10156-011-0273-7. Epub 2011 Jul 8.

PMID:
21739106
15.

Mutational and transcriptional analyses of the Staphylococcus aureus low-affinity proline transporter OpuD during in vitro growth and infection of murine tissues.

Wetzel KJ, Bjorge D, Schwan WR.

FEMS Immunol Med Microbiol. 2011 Apr;61(3):346-55. doi: 10.1111/j.1574-695X.2011.00781.x. Epub 2011 Feb 7. Erratum in: FEMS Immunol Med Microbiol. 2012 Mar;64(2):292-3.

16.

Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates.

Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, Lynfield R, Schwan WR.

J Clin Microbiol. 2010 Oct;48(10):3582-92. doi: 10.1128/JCM.00657-10. Epub 2010 Jul 28.

17.

A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivatives.

Kabir MS, Namjoshi OA, Verma R, Polanowski R, Krueger SM, Sherman D, Rott MA, Schwan WR, Monte A, Cook JM.

Bioorg Med Chem. 2010 Jun 15;18(12):4178-86. doi: 10.1016/j.bmc.2010.05.016. Epub 2010 May 7.

PMID:
20537903
18.

Use of optical mapping to sort uropathogenic Escherichia coli strains into distinct subgroups.

Schwan WR, Briska A, Stahl B, Wagner TK, Zentz E, Henkhaus J, Lovrich SD, Agger WA, Callister SM, DuChateau B, Dykes CW.

Microbiology. 2010 Jul;156(Pt 7):2124-35. doi: 10.1099/mic.0.033977-0. Epub 2010 Apr 8.

19.

Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.

Schwan WR, Dunek C, Gebhardt M, Engelbrecht K, Klett T, Monte A, Toce J, Rott M, Volk TJ, LiPuma JJ, Liu XT, McKelvey R.

Ann Clin Microbiol Antimicrob. 2010 Jan 21;9:4. doi: 10.1186/1476-0711-9-4.

20.

Antibacterial compounds from mushrooms II: lanostane triterpenoids and an ergostane steroid with activity against Bacillus cereus isolated from Fomitopsis pinicola.

Liu XT, Winkler AL, Schwan WR, Volk TJ, Rott M, Monte A.

Planta Med. 2010 Mar;76(5):464-6. doi: 10.1055/s-0029-1186227. Epub 2009 Oct 21.

PMID:
19847745
21.
22.

Survival of uropathogenic Escherichia coli in the murine urinary tract is dependent on OmpR.

Schwan WR.

Microbiology. 2009 Jun;155(Pt 6):1832-9. doi: 10.1099/mic.0.026187-0. Epub 2009 Apr 21.

23.

New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis.

Shahjahan Kabir M, Engelbrecht K, Polanowski R, Krueger SM, Ignasiak R, Rott M, Schwan WR, Stemper ME, Reed KD, Sherman D, Cook JM, Monte A.

Bioorg Med Chem Lett. 2008 Nov 1;18(21):5745-9. doi: 10.1016/j.bmcl.2008.09.085. Epub 2008 Sep 26.

PMID:
18849164
24.

Flagella allow uropathogenic Escherichia coli ascension into murine kidneys.

Schwan WR.

Int J Med Microbiol. 2008 Jul;298(5-6):441-7. Epub 2007 Sep 20.

25.

The two-component response regulator RcsB regulates type 1 piliation in Escherichia coli.

Schwan WR, Shibata S, Aizawa S, Wolfe AJ.

J Bacteriol. 2007 Oct;189(19):7159-63. Epub 2007 Jul 20.

26.

An assessment of emergency preparedness in western Wisconsin.

Gilmore GD, Schwan WR, McLaughlin MK.

WMJ. 2007 Apr;106(2):71-7.

27.

PCR-based detection of DNA from the human pathogen Blastomyces dermatitidis from natural soil samples.

Burgess JW, Schwan WR, Volk TJ.

Med Mycol. 2006 Dec;44(8):741-8.

PMID:
17127631
28.

Significant pathogens isolated from surgical site infections at a community hospital in the Midwest.

Cantlon CA, Stemper ME, Schwan WR, Hoffman MA, Qutaishat SS.

Am J Infect Control. 2006 Oct;34(8):526-9.

PMID:
17015159
30.

Mutations in the cueA gene encoding a copper homeostasis P-type ATPase reduce the pathogenicity of Pseudomonas aeruginosa in mice.

Schwan WR, Warrener P, Keunz E, Stover CK, Folger KR.

Int J Med Microbiol. 2005 Aug;295(4):237-42.

PMID:
16128398
31.

Down-regulation of the kps region 1 capsular assembly operon following attachment of Escherichia coli type 1 fimbriae to D-mannose receptors.

Schwan WR, Beck MT, Hultgren SJ, Pinkner J, Woolever NL, Larson T.

Infect Immun. 2005 Feb;73(2):1226-31.

32.

Low-proline environments impair growth, proline transport and in vivo survival of Staphylococcus aureus strain-specific putP mutants.

Schwan WR, Wetzel KJ, Gomez TS, Stiles MA, Beitlich BD, Grunwald S.

Microbiology. 2004 Apr;150(Pt 4):1055-61.

PMID:
15073314
33.
34.
35.

Differences in sensitivity to PA-1806 among iron transport mutants of Pseudomonas aeruginosa compared to Escherichia coli.

Schwan WR, Barker L, Brody LL.

Antimicrob Agents Chemother. 2000 Nov;44(11):3237-8. No abstract available.

36.
37.
38.

Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.

Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, Hufnagle WO, Folger KR, Bayer AS, Stover CK.

Mol Microbiol. 1998 Oct;30(2):393-404.

39.

Physical limitations on Salmonella typhi entry into cultured human intestinal epithelial cells.

Huang XZ, Tall B, Schwan WR, Kopecko DJ.

Infect Immun. 1998 Jun;66(6):2928-37.

40.

Identification and characterization of the PutP proline permease that contributes to in vivo survival of Staphylococcus aureus in animal models.

Schwan WR, Coulter SN, Ng EY, Langhorne MH, Ritchie HD, Brody LL, Westbrock-Wadman S, Bayer AS, Folger KR, Stover CK.

Infect Immun. 1998 Feb;66(2):567-72.

42.

Serovar specific differences in Salmonella survival within macrophage cells.

Schwan WR, Kopecko DJ.

Adv Exp Med Biol. 1997;412:277-8. No abstract available.

PMID:
9192030
43.
44.
47.

Analysis of the fimB promoter region involved in type 1 pilus phase variation in Escherichia coli.

Schwan WR, Seifert HS, Duncan JL.

Mol Gen Genet. 1994 Mar;242(5):623-30.

PMID:
8121417
48.
49.

Bacteria as solid phase in a concentration fluorescence immunoassay analysis of antibodies to surface antigens.

Schwan WR, Waltenbaugh C, Duncan JL.

J Immunol Methods. 1990 Feb 9;126(2):247-52.

PMID:
1968082
50.

In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections.

Kisielius PV, Schwan WR, Amundsen SK, Duncan JL, Schaeffer AJ.

Infect Immun. 1989 Jun;57(6):1656-62.

Supplemental Content

Loading ...
Support Center